The global Alopecia Treatment Market is estimated to be valued at US$ 9.65 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Alopecia treatment market covers treatment products and therapies for alopecia(hair loss). Alopecia areata is an autoimmune skin disease that results in patches of hair loss on the scalp, face, and sometimes on other areas of the body. Growing population, increasing awareness about hair loss treatment and rising cases of alopecia are some of the major factors driving the alopecia treatment market. Various treatment options available in the market includes topical players, oral supplements and medications, lasers and LED technology etc. which help in preventing further hair loss and stimulate hair regrowth.

Market Key Trends:
The alopecia treatment market is witnessing significant growth due to rising research and development activities. Key players are focusing on developing novel treatment products to target the underlying cause of alopecia. Stemson Therapeutics is developing its lead product, STM101 to restore hair growth in people with alopecia areata by reprogramming their immune system cells. OliX Pharmaceuticals, Inc is developing OLX1000 for androgenic alopecia. Ongoing clinical trials and new product launches are some of the major trends driving the growth of alopecia treatment market. In addition, increasing popularity of low-level light therapy (LLLT) or lasers for treating alopecia areata is fueling the market growth.
Porter's Analysis

Threat of new entrants: The alopecia treatment market requires high R&D investment and clinical trials for new drugs. This poses high entry barriers for new players.
Bargaining power of buyers: The bargaining power of buyers is moderate due to the availability of generic drugs and presence of many established players.
Bargaining power of suppliers: Major suppliers in this market include drug manufacturers and raw material suppliers. Their bargaining power is moderate due to availability of substitute options.
Threat of new substitutes: Threat from new substitutes is high as new effective therapies can replace existing treatment options.
Competitive rivalry: The alopecia treatment market witnesses high competition due to presence of many global and local players.

Key Takeaways

The Global Alopecia Treatment Market Demand is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing prevalence of alopecia and launch of novel therapies.

Regional analysis

North America dominates the alopecia treatment market due to rising incidence of alopecia and presence of major market players in the region. However, Asia Pacific is expected to witness fastest growth over the forecast period owing increasing healthcare expenditure and expansion of key players in emerging countries.

Key players

Key players operating in the alopecia treatment market are Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddyâ€TMs Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.Â

Read More:

https://www.marketwebjournal.com/alopecia-treatment-market-growth-demand-and-size/